Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity

Clinical and Experimental Immunology

Volumn 179, Issue 1, 2015, Pages 39-49

  Zirngibl, M ^a,b   Furnrohr B G ^a,d   Janko, C ^a   Munoz, L E ^a   Voll, R E ^c   Gregory, C D ^e   Schett, G ^a   Herrmann, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Blebbing; Nuclear autoantigens; Systemic lupus erythematosus

Indexed keywords

AUTOANTIGEN; GREEN FLUORESCENT PROTEIN; HISTONE H2B; MYOSIN LIGHT CHAIN KINASE; NUCLEAR AUTOANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; APOPTOTIC CELL DERIVED MEMBRANOUS VESICLE; ARTICLE; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MEMBRANE VESICLE; MICROTUBULE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOLOGICAL MODEL; CELL LINE; CYTOSKELETON; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; NUCLEAR SIZE; RADIATION RESPONSE;

APOPTOSIS; AUTOANTIGENS; CELL LINE; CELL NUCLEUS SIZE; CELL-DERIVED MICROPARTICLES; CYTOSKELETON; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICROTUBULES; MODELS, BIOLOGICAL; MYOSIN-LIGHT-CHAIN KINASE;

EID: 84939215881     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12342     Document Type: Article

References (46)

1. Hasegawa M, Sato S, Kikuchi K, Takehara K. Antigen specificity of antihistone antibodies in systemic sclerosis. Ann Rheum Dis 1998; 57:470-475.
2. Wayaku T, Hasegawa M, Kaji K etal. Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies. Rheumatol Int 2007; 28:113-119.
3. Ostensen M, Fredriksen K, Kass E, Rekvig OP. Identification of antihistone antibodies in subsets of juvenile chronic arthritis. Ann Rheum Dis 1989; 48:114-117.
4. Leak AM, Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann Rheum Dis 1991; 50:653-657.
5. Gompertz NR, Isenberg DA, Turner BM. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. Ann Rheum Dis 1990; 49:524-527.
6. Munoz LE, Janko C, Schulze C etal. Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 2010; 10:38-42.
7. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6:280-289.
8. Munoz LE, Janko C, Grossmayer GE etal. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 2009; 60:1733-1742.
9. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
10. Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102:1-4.
11. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389:251-260.
12. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001; 276:7320-7326.
13. Broers JL, Bronnenberg NM, Kuijpers HJ, Schutte B, Hutchison CJ, Ramaekers FC. Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis. Eur J Cell Biol 2002; 81:677-691.
14. Charras GT, Hu CK, Coughlin M, Mitchison TJ. Reassembly of contractile actin cortex in cell blebs. J Cell Biol 2006; 175:477-490.
15. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391:43-50.
16. Herrmann M, Lorenz HM, Voll R, Grunke M, Woith W, Kalden JR. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 1994; 22:5506-5507.
17. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 1990; 347:286-289.
18. Fadeel B, Xue D, Kagan V. Programmed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of inflammation. Biochem Biophys Res Commun 2010; 396:7-10.
19. Geske FJ, Monks J, Lehman L, Fadok VA. The role of the macrophage in apoptosis: hunter, gatherer, and regulator. Int J Hematol 2002; 76:16-26.
20. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41:1241-1250.
21. Hanayama R, Tanaka M, Miyasaka K etal. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304:1147-1150.
22. Kitahara Y, Kawane K, Nagata S. Interferon-induced TRAIL-independent cell death in DNase II-/- embryos. Eur J Immunol 2010; 40:2590-2598.
23. Ogden CA, Kowalewski R, Peng Y, Montenegro V, Elkon KB. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 2005; 38:259-264.
24. Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 2003; 170:3223-3232.
25. Kruse K, Janko C, Urbonaviciute V etal. Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis 2010; 15:1098-1113.
26. Scott VR, Boehme R, Matthews TR. New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species. Antimicrob Agents Chemother 1988; 32:1154-1157.
27. Bubb MR, Senderowicz AM, Sausville EA, Duncan KL, Korn ED. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 1994; 269:14869-14871.
28. Spector I, Shochet NR, Kashman Y, Groweiss A. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science 1983; 219:493-495.
29. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001; 3:339-345.
30. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003; 4:446-456.
31. Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001; 3:346-352.
32. Cheung A, Dantzig JA, Hollingworth S etal. A small-molecule inhibitor of skeletal muscle myosin II. Nat Cell Biol 2002; 4:83-88.
33. Lowe J, Li H, Downing KH, Nogales E. Refined structure of alpha beta-tubulin at 3.5 A resolution. J Mol Biol 2001; 313:1045-1057.
34. Saitoh M, Ishikawa T, Matsushima S, Naka M, Hidaka H. Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem 1987; 262:7796-7801.
35. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 2004; 14:277-287.
36. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997; 390:350-351.
37. Bilyy RO, Shkandina T, Tomin A etal. Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles. J Biol Chem 2012; 287:496-503.
38. Franz S, Herrmann K, Furnrohr BG etal. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ 2007; 14:733-742.
39. Baumann I, Kolowos W, Voll RE etal. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46:191-201.
40. Berkel AI, Birben E, Oner C, Oner R, Loos M, Petry F. Molecular, genetic and epidemiologic studies on selective complete C1q deficiency in Turkey. Immunobiology 2000; 201:347-355.
41. Jonsson G, Truedsson L, Sturfelt G, Oxelius VA, Braconier JH, Sjoholm AG. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine 2005; 84:23-34.
42. Ripoche J, Fontaine M, Godin M, Hauptmann G, Goetz J. Partial deficiency of the fourth component of human complement (C4) and autoantibody directed against C4 in a patient with SLE. Ann Immunol (Paris) 1983; 134D:233-245.
43. Rhodes B, Furnrohr BG, Roberts AL etal. The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann Rheum Dis 2012; 71:2028-2034.
44. Grossmayer GE, Munoz LE, Weber CK etal. IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Ann Rheum Dis 2008; 67:1626-1632.
45. Schiller M, Bekeredjian-Ding I, Heyder P, Blank N, Ho AD, Lorenz HM. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008; 15:183-191.
46. Schiller M, Parcina M, Heyder P etal. Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles. J Immunol 2012; 189:1747-1756.